N-(3-Cyanophenyl)-2-(3-(6-methylpyridin-2-yl)-4-(thieno[3,2-c]pyridin-2-yl)-1H-pyrazol-1-yl)acetamide

ID: ALA4531718

PubChem CID: 155546431

Max Phase: Preclinical

Molecular Formula: C25H18N6OS

Molecular Weight: 450.53

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2cc3cnccc3s2)n1

Standard InChI:  InChI=1S/C25H18N6OS/c1-16-4-2-7-21(28-16)25-20(23-11-18-13-27-9-8-22(18)33-23)14-31(30-25)15-24(32)29-19-6-3-5-17(10-19)12-26/h2-11,13-14H,15H2,1H3,(H,29,32)

Standard InChI Key:  LKUXFOGPQZASDQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   39.2948  -21.1209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0037  -21.5259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0904  -22.3385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8900  -22.5072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.2975  -21.7988    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.7497  -21.1924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4858  -22.8835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7079  -22.6300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1028  -23.1740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2700  -23.9742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0479  -24.2277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6586  -23.6809    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.2163  -25.0273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.1142  -21.7959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5253  -22.5022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3425  -22.4993    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.1192  -23.2113    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.7536  -23.2056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3450  -23.9119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7554  -24.6177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.5734  -24.6152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.9794  -23.9011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.5666  -23.1983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2039  -20.3090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5485  -21.4559    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   37.9994  -20.8517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4054  -20.1476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9987  -19.4461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1862  -19.4474    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.7821  -20.1562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1911  -20.8548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.7956  -23.8922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.6128  -23.8865    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  2  2  0
  1  2  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  3  7  1  0
 11 13  1  0
  5 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
  1 24  2  0
 24 27  1  0
 26 25  1  0
 25  1  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 32 33  3  0
 22 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4531718

    ---

Associated Targets(Human)

TGFBR1 Tchem TGF-beta receptor type I (3786 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 450.53Molecular Weight (Monoisotopic): 450.1263AlogP: 5.04#Rotatable Bonds: 5
Polar Surface Area: 96.49Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.96CX Basic pKa: 3.67CX LogP: 3.80CX LogD: 3.80
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.40Np Likeness Score: -2.10

References

1. Zhu WJ, Cui BW, Wang HM, Nan JX, Piao HR, Lian LH, Jin CH..  (2019)  Design, synthesis, and antifibrosis evaluation of 4-(benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole derivatives.,  180  [PMID:31299584] [10.1016/j.ejmech.2019.07.013]

Source